SCHEDULE 13G: State Street Corporation Discloses 4.9% Passive Stake in Arcturus Therapeutics Holdings Inc.
Beneficial Ownership Disclosure
State Street Corporation has filed a Schedule 13G, reporting a passive beneficial ownership of 4.9% of Arcturus Therapeutics Holdings Inc.'s common stock as of December 31, 2024.
Summary
- State Street Corporation, a Massachusetts-based parent holding company, has filed a Schedule 13G with the SEC.
- The filing indicates that State Street Corporation beneficially owns 1,326,158 shares of common stock in Arcturus Therapeutics Holdings Inc.
- This ownership represents 4.9% of the class of securities, falling just below the 5% threshold that would typically trigger a Schedule 13D filing for active investors.
- State Street Corporation holds shared voting power over 1,214,694 shares and shared dispositive power over all 1,326,158 shares.
- The shares are held in the ordinary course of business and not for the purpose of changing or influencing the control of Arcturus Therapeutics Holdings Inc., as certified by State Street Corporation.
Sentiment
Score: 5
Explanation: The filing is a standard regulatory disclosure of passive beneficial ownership and does not contain information that would significantly alter the company's outlook or valuation.
Positives
- The disclosure of State Street Corporation's passive stake could be viewed as a vote of confidence from a major institutional investor in Arcturus Therapeutics Holdings Inc.
Future Outlook
N/A This filing is a disclosure of passive beneficial ownership and does not contain forward-looking statements or guidance from the issuer.
Industry Context
N/A This Schedule 13G filing primarily concerns an institutional investor's passive ownership stake and does not provide information on broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event which requires filing of this statement (reporting period end date). |
| 01/31/2025 | Date the Schedule 13G was signed by State Street Corporation. |
Keywords
Arcturus Therapeutics Holdings Inc, State Street Corporation, Schedule 13G, beneficial ownership, passive investment, common stock, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.